SCHEMBL5228519

SCHEMBL5228519

O=C1C=C(c2ccc(Br)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.39
PTPRC P08575 1/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPK1 P28482 2/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 1/20 0.36
CYP2A6 P11509 1/20 0.36
TSHR P16473 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CA12 O43570 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
GALR1 P47211 1/20 0.33
TDP2 O95551 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5225774 0.87 HTR2C (0.37) HTR2CPTPRCALDH1A1MAPK1MEN1
SCHEMBL29489302 0.84 HTR2C (0.41) HTR2CPTPRCALDH1A1MAPK1MEN1
SCHEMBL728223 0.77 NPC1 (0.39) ALDH1A1MAPK1MEN1KMT2ANPC1
SCHEMBL28522627 0.72 ALDH1A1 (0.43) HTR2CPTPRCALDH1A1MAPK1MEN1
SCHEMBL7488496 0.72 IDO1 (0.38) ALDH1A1MAPK1MEN1KMT2ANPC1
SCHEMBL29079989 0.72 ALDH1A1 (0.36) HTR2CPTPRCALDH1A1MAPK1MEN1
SCHEMBL8649025 0.72 PTGS2 (0.42) ALDH1A1MAPK1MEN1KMT2AGAA
SCHEMBL15258336 0.71 HSD17B1 (0.48) MAPK1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL728161 0.71 AHR (0.48) ALDH1A1MEN1KMT2AGAAMAPT
Hydrochloric Acid SCHEMBL27699821 0.71 BACE1 (0.44) TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737824-A2 NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, AND MEDICAMENTS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-03 EP disclosed
US-20050245529-A1 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 US disclosed
WO-2005103032-A2 NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, AND MEDICAMENTS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245529-A1 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds MCHR1, GPR119, MCHR2 HTR2C 301/4885PTPRC 2859/4885ALDH1A1 3033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.